44 related articles for article (PubMed ID: 38700373)
21. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).
Li P; Huang P; Yang Y; Hao M; Peng H; Li F
Clin Rev Allergy Immunol; 2016 Feb; 50(1):55-63. PubMed ID: 25663566
[TBL] [Abstract][Full Text] [Related]
22. The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.
Rieux-Laucat F; Magérus-Chatinet A; Neven B
J Clin Immunol; 2018 Jul; 38(5):558-568. PubMed ID: 29911256
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation.
Paskiewicz A; Niu J; Chang C
Autoimmun Rev; 2023 Nov; 22(11):103442. PubMed ID: 37683818
[TBL] [Abstract][Full Text] [Related]
24. [Autoimmune lymphoproliferative syndrome. Update and review].
Suárez-Gutiérrez M; Yamazaki-Nakashimada MA; Espinosa S; Blancas-Galicia L; Lugo-Reyes SO; Álvarez-Cardona A
Rev Alerg Mex; 2019; 66(4):456-473. PubMed ID: 32105427
[TBL] [Abstract][Full Text] [Related]
25. Presentation and diagnosis of autoimmune lymphoproliferative syndrome (ALPS).
Lambert MP
Expert Rev Clin Immunol; 2021 Nov; 17(11):1163-1173. PubMed ID: 34503378
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders.
Magerus A; Rensing-Ehl A; Rao VK; Teachey DT; Rieux-Laucat F; Ehl S
J Allergy Clin Immunol; 2024 Jan; 153(1):67-76. PubMed ID: 37977527
[TBL] [Abstract][Full Text] [Related]
27. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.
Consonni F; Gambineri E; Favre C
Ann Hematol; 2022 Mar; 101(3):469-484. PubMed ID: 35059842
[TBL] [Abstract][Full Text] [Related]
28. Inherited and acquired death receptor defects in human Autoimmune Lymphoproliferative Syndrome.
Rieux-Laucat F
Curr Dir Autoimmun; 2006; 9():18-36. PubMed ID: 16394653
[TBL] [Abstract][Full Text] [Related]
29. Advances in autoimmune lymphoproliferative syndromes.
Madkaikar M; Mhatre S; Gupta M; Ghosh K
Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
[TBL] [Abstract][Full Text] [Related]
30. Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children.
George LA; Teachey DT
Paediatr Drugs; 2016 Aug; 18(4):261-72. PubMed ID: 27139496
[TBL] [Abstract][Full Text] [Related]
31. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.
Teachey DT
Curr Opin Pediatr; 2012 Feb; 24(1):1-8. PubMed ID: 22157362
[TBL] [Abstract][Full Text] [Related]
32. Thymic functions and gene expression profile distinct double-negative cells from single positive cells in the autoimmune lymphoproliferative syndrome.
Lev A; Simon AJ; Amariglio N; Rechavi G; Somech R
Autoimmun Rev; 2012 Aug; 11(10):723-30. PubMed ID: 22273982
[TBL] [Abstract][Full Text] [Related]
33. Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes.
Gámez-Díaz L; Grimbacher B
Biomed J; 2021 Aug; 44(4):400-411. PubMed ID: 34384744
[TBL] [Abstract][Full Text] [Related]
34. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.
Oliveira JB; Bleesing JJ; Dianzani U; Fleisher TA; Jaffe ES; Lenardo MJ; Rieux-Laucat F; Siegel RM; Su HC; Teachey DT; Rao VK
Blood; 2010 Oct; 116(14):e35-40. PubMed ID: 20538792
[TBL] [Abstract][Full Text] [Related]
35. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).
Teachey DT; Seif AE; Grupp SA
Br J Haematol; 2010 Jan; 148(2):205-16. PubMed ID: 19930184
[TBL] [Abstract][Full Text] [Related]
36. The autoimmune lymphoproliferative syndrome: A rare disorder providing clues about normal tolerance.
Turbyville JC; Rao VK
Autoimmun Rev; 2010 May; 9(7):488-93. PubMed ID: 20170754
[TBL] [Abstract][Full Text] [Related]
37. Protein Kinase C-Delta Defect in Autoimmune Lymphoproliferative Syndrome-Like Disease: First Case from the National Iranian Registry and Review of the Literature.
Sharifinejad N; Azizi G; Behniafard N; Zaki-Dizaji M; Jamee M; Yazdani R; Abolhassani H; Aghamohammadi A
Immunol Invest; 2022 Feb; 51(2):331-342. PubMed ID: 33047643
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune Lymphoproliferative Syndrome: An Overview.
Matson DR; Yang DT
Arch Pathol Lab Med; 2020 Feb; 144(2):245-251. PubMed ID: 30958694
[TBL] [Abstract][Full Text] [Related]
39. [Advances in the knowledge and management of autoimmune lymphoproliferative syndrome].
Garrido Colino C
An Pediatr (Barc); 2014 Feb; 80(2):122.e1-7. PubMed ID: 24055319
[TBL] [Abstract][Full Text] [Related]
40. Looking for ALPS: The value of a combined assessment of biochemical markers.
Fernandez I; Touzot F
Pediatr Allergy Immunol; 2024 May; 35(5):e14135. PubMed ID: 38700373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
